It was reported that on (b)(6) 2019, a 3.25x08, 3.50x12mm, 3.50x23mm xience sierra stents were implanted without reported issues.On (b)(6) 2019, the patient was re-admitted to the hospital for atherosclerotic heart disease and other cardiovascular symptoms.Unspecified treatment was provided.No coronary imaging was reported and there was no additional percutaneous coronary intervention performed.The patient has been discharged home.No additional information was provided regarding this issue.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Patient code 3190 removed.
|